LU500595B1 - miR-16 and miR-30c joint Expression Vector, Construction Method and their Use - Google Patents

miR-16 and miR-30c joint Expression Vector, Construction Method and their Use Download PDF

Info

Publication number
LU500595B1
LU500595B1 LU500595A LU500595A LU500595B1 LU 500595 B1 LU500595 B1 LU 500595B1 LU 500595 A LU500595 A LU 500595A LU 500595 A LU500595 A LU 500595A LU 500595 B1 LU500595 B1 LU 500595B1
Authority
LU
Luxembourg
Prior art keywords
mir
neural stem
expression vector
stem cells
alzheimer
Prior art date
Application number
LU500595A
Other languages
German (de)
English (en)
Inventor
Tianpeng Li
Tingting Sun
Original Assignee
Univ Zaozhuang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Zaozhuang filed Critical Univ Zaozhuang
Application granted granted Critical
Publication of LU500595B1 publication Critical patent/LU500595B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C12N2310/141—MicroRNAs, miRNAs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/20—Vector systems having a special element relevant for transcription transcription of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU500595A 2020-07-28 2020-11-06 miR-16 and miR-30c joint Expression Vector, Construction Method and their Use LU500595B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010735788.6A CN111850047B (zh) 2020-07-28 2020-07-28 一种miR-16与miR-30c联合表达载体及其构建方法与应用

Publications (1)

Publication Number Publication Date
LU500595B1 true LU500595B1 (en) 2022-01-28

Family

ID=72947907

Family Applications (1)

Application Number Title Priority Date Filing Date
LU500595A LU500595B1 (en) 2020-07-28 2020-11-06 miR-16 and miR-30c joint Expression Vector, Construction Method and their Use

Country Status (3)

Country Link
CN (1) CN111850047B (fr)
LU (1) LU500595B1 (fr)
WO (1) WO2022021660A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111850047B (zh) * 2020-07-28 2022-08-12 枣庄学院 一种miR-16与miR-30c联合表达载体及其构建方法与应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103866018B (zh) * 2005-08-01 2016-05-25 俄亥俄州立大学研究基金会 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
CN101296702B (zh) * 2005-09-12 2012-11-28 俄亥俄州立大学研究基金会 用于诊断或治疗bcl2相关癌症的组合物和方法
CN101787373B (zh) * 2009-01-23 2013-06-19 中国人民解放军第二军医大学东方肝胆外科医院 一种携带外源基因在包装细胞中高效生产的重组病毒载体、其构建方法及其用途
EP2437750A4 (fr) * 2009-05-20 2014-11-05 Univ Texas Identification de micro-arn impliqués dans un remodelage post-infarctus du myocarde et une insuffisance cardiaque
JP2015509366A (ja) * 2012-02-22 2015-03-30 ブレインステム バイオテック リミテッド 神経幹細胞および運動ニューロンの生成
EP2833893B1 (fr) * 2012-04-03 2018-08-29 Reneuron Limited Microparicules de cellules souches
WO2014016817A2 (fr) * 2012-07-17 2014-01-30 Universite De Geneve Acides nucléiques pour la régulation à la baisse de l'expression génique
CA2879322A1 (fr) * 2012-07-19 2014-01-23 Reneuron Limited Microparticules de cellules souches
CN103667347A (zh) * 2012-09-08 2014-03-26 刘佳 一种高效表达抗癌基因的受特定miRNA调控的在胶质瘤细胞中特异增殖的腺病毒及其用途
US11293064B2 (en) * 2013-05-02 2022-04-05 Thomas Jefferson University Human miRNAs for use in diagnosis, prognosis, and therapy of human conditions and diseases
WO2016150475A1 (fr) * 2015-03-22 2016-09-29 Universite De Liege Micro-arn circulants pour diagnostiquer le cancer du sein
JP2019514416A (ja) * 2016-05-16 2019-06-06 エグゾステム バイオテック リミテッド 間葉系幹細胞と筋損傷及び筋肉関連疾患の治療のための間葉系幹細胞の使用
CN111093769A (zh) * 2017-08-01 2020-05-01 英联邦高等教育系统天普大学 来源于皮质骨干细胞的外来体可以增强心脏损伤后的心脏功能
CN111850047B (zh) * 2020-07-28 2022-08-12 枣庄学院 一种miR-16与miR-30c联合表达载体及其构建方法与应用

Also Published As

Publication number Publication date
CN111850047B (zh) 2022-08-12
WO2022021660A1 (fr) 2022-02-03
CN111850047A (zh) 2020-10-30

Similar Documents

Publication Publication Date Title
Oka et al. VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells
Liu et al. Ascl1 converts dorsal midbrain astrocytes into functional neurons in vivo
RU2535365C2 (ru) Способы получения и применения мультипотентных клеточных популяций
CA2939535A1 (fr) Utilisation d'un alphavirus dans la preparation de medicaments antitumoraux
Meng et al. Induction of retinal ganglion-like cells from fibroblasts by adenoviral gene delivery
CN105492597A (zh) 利用hmga2制备由非神经元细胞重编程的诱导神经干细胞的方法
Xue et al. Nestin expression in Müller glial cells in postnatal rat retina and its upregulation following optic nerve transection
WO2023169092A1 (fr) Car-monocyte/macrophage régulé par le micro-environnement tumoral, son procédé de préparation et son utilisation
LU500595B1 (en) miR-16 and miR-30c joint Expression Vector, Construction Method and their Use
Deng et al. Mash-1 modified neural stem cells transplantation promotes neural stem cells differentiation into neurons to further improve locomotor functional recovery in spinal cord injury rats
Zhai et al. Overexpressed ski efficiently promotes neurorestoration, increases neuronal regeneration, and reduces astrogliosis after traumatic brain injury
US20090227023A1 (en) DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh
Masjkur et al. Neurovascular signals suggest a propagation mechanism for endogenous stem cell activation along blood vessels
Gao et al. Differentiation of GDNF and NT-3 dual gene-modified rat bone marrow mesenchymal stem cells into enteric neuron-like cells
CN108866100A (zh) 一种高效率的基因编辑方法
CN105535992B (zh) Ascl1在诱导星形胶质细胞转分化为功能性神经元中的应用
CN111676222A (zh) 抑制Mettl3基因表达的shRNA及其重组腺相关病毒与应用
US20240026379A1 (en) Functional fragment for reprogramming, composition, and application thereof
IT201600093825A1 (it) Composizione farmaceutica di miRNA e suoi usi terapeutici.
WO2021228050A1 (fr) Procédé d'induction d'une transdifférenciation de cellules gliales en neurones fonctionnels, et application associée
KR101548616B1 (ko) 중간엽 줄기세포를 ｇａβａ성 신경세포로 분화시키는 방법 및 ｂｄｎｆ를 포함하는 ｇａβａ성 신경세포 분화유도용 조성물
CN104531709A (zh) 抑制肿瘤生长与转移的siRNA双干扰组合物及其应用
WO2021055081A1 (fr) Tissus de type muscle endothéliaux et lisses produits à partir de cellules urinaires et utilisations associées
CN108795987A (zh) 一种FerritinH、Bcl2及EGFP基因联合修饰的神经干细胞制备方法及应用
CN113652428B (zh) 核膜蛋白敲降在干细胞移植方面的应用

Legal Events

Date Code Title Description
FG Patent granted

Effective date: 20220128